Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004375906 | SCV004857868 | uncertain significance | Inborn genetic diseases | 2024-03-05 | criteria provided, single submitter | clinical testing | The c.3026A>T (p.N1009I) alteration is located in exon 22 (coding exon 22) of the ABCA12 gene. This alteration results from a A to T substitution at nucleotide position 3026, causing the asparagine (N) at amino acid position 1009 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |